论文部分内容阅读
我国是高血压大国,高血压治疗对于重大心血管疾病防治,早日迎接心血管事件拐点具有重要意义。血管紧张素转换酶抑制剂(angiotensin converting enzyme inhibitors,ACEI)作为一线降压药物,具备良好的降压和心血管保护作用。它的发明是心血管治疗史上的里程碑。如今,距离首个ACEI问世,已经整整40年,大量的循证证据夯实了ACEI在高血压、冠心病和心衰等疾病治疗中的基石地位。时至
China is a big country with hypertension. Hypertension treatment is of great significance to the prevention and treatment of major cardiovascular diseases and to meet the inflection point of cardiovascular events as soon as possible. Angiotensin converting enzyme inhibitors (angiotensin converting enzyme inhibitors, ACEI) as a front-line antihypertensive drugs, with good antihypertensive and cardiovascular protection. Its invention is a milestone in the history of cardiovascular therapies. It has been 40 years since the first ACEI was introduced, and substantial evidence-based evidence reinforces the cornerstone of ACE inhibitors in the treatment of diseases such as hypertension, coronary heart disease and heart failure. Time to